[
    [
        {
            "time": "2022-11-05",
            "original_text": "Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down",
            "features": {
                "keywords": [
                    "Merck",
                    "COVID",
                    "Pill",
                    "Less Effective",
                    "Final Study",
                    "Stock Down"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Merck (MRK) COVID Pill Less Effective in Final Study, Stock Down",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2022-11-05",
            "original_text": "Adagio Therapeutics Upgraded at Morgan Stanley on Omicron Potential",
            "features": {
                "keywords": [
                    "Adagio Therapeutics",
                    "Upgraded",
                    "Morgan Stanley",
                    "Omicron",
                    "Potential"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotechnology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Adagio Therapeutics Upgraded at Morgan Stanley on Omicron Potential",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]